SCHEMBL23188409

SCHEMBL23188409

CCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN(C)C)OC(=O)CCCCCCCCCCCCC

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SELP P16109 1/20 0.68
FABP3 P05413 1/20 0.65
LPAR3 Q9UBY5 5/20 0.62
LPAR1 Q92633 4/20 0.62
ENPP2 Q13822 3/20 0.61
SMN1; SMN2 Q16637 1/20 0.60
PRKCE Q02156 1/20 0.59
PRKCQ Q04759 1/20 0.59
PRKCD Q05655 1/20 0.59
PRKCA P17252 1/20 0.59
NR5A2 O00482 1/20 0.59
NR5A1 Q13285 1/20 0.59
DAGLA Q9Y4D2 1/20 0.58
RECQL P46063 1/20 0.57
BLM P54132 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
P2RY10 O00398 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30555851 1.00 SELP (0.68) SELPFABP3LPAR3LPAR1ENPP2
SCHEMBL18515632 1.00 SELP (0.68) SELPFABP3LPAR3LPAR1ENPP2
SCHEMBL14887282 1.00 SELP (0.68) SELPFABP3LPAR3LPAR1ENPP2
SCHEMBL18350894 1.00 SELP (0.68) SELPFABP3LPAR3LPAR1ENPP2
SCHEMBL23188454 1.00 SELP (0.68) SELPFABP3LPAR3LPAR1ENPP2
SCHEMBL23225813 1.00 SELP (0.68) SELPFABP3LPAR3LPAR1ENPP2
SCHEMBL22993609 1.00 SELP (0.68) SELPFABP3LPAR3LPAR1ENPP2
SCHEMBL23188412 1.00 SELP (0.68) SELPFABP3LPAR3LPAR1ENPP2
SCHEMBL15336893 1.00 SELP (0.68) SELPFABP3LPAR3LPAR1ENPP2
SCHEMBL17213399 1.00 SELP (0.68) SELPFABP3LPAR3LPAR1ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210100905-A1 APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) 2021-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210100905-A1 APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS TRDMT1, SNRPE, HNRNPAB SELP 3490/4885FABP3 648/4885LPAR3 1068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.